BPC-157

Also known as: Body Protection Compound 157, PL 14736, Bepecin

Research chemical

A synthetic 15-amino-acid peptide with striking tissue-healing effects in rodent studies — and essentially no controlled human evidence. Sold as a research chemical, not an approved drug.

Not approved by the FDA for any use. Sold for laboratory research only. Placed on the FDA's category-2 bulk-compounding list (substances with significant safety risks), which restricts compounding pharmacies from using it.

What it is

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence found in human gastric juice. In animal research it has shown a broad, almost implausibly wide range of tissue-protective and healing effects. It is one of the most-searched “research peptides” — and one where the gap between online claims and actual human evidence is widest.

What it’s approved or studied for

Nothing. BPC-157 is not approved by the FDA for any use and is sold for laboratory research only. Nearly all of the supporting data come from rodent studies. There are no adequate, controlled human trials establishing that it works or that it is safe.

What human evidence exists

Effectively none of the controlled kind. The healing claims — tendon, ligament, gut, muscle — rest on Grade D preclinical evidence: animal, cell, and mechanistic studies. That evidence is genuinely interesting and consistent enough to justify human trials, but it does not establish effectiveness or safety in people. Long-term human safety is Grade U: unknown.

The major unknowns

Human pharmacokinetics, effective dose, long-term safety, and whether any of the rodent benefits translate to humans are all open questions. Compound purity is a further problem: research-chemical supply is unregulated, so what’s in a given vial is uncertain.

Most important safety considerations

Because there is no controlled human safety data, the honest answer to “is it safe?” is that no one knows. Product quality is uncontrolled, it is prohibited in sport under WADA’s S0 category, and it is not a legal therapeutic. This page summarizes the research record; it is not medical advice or an endorsement of use.

Evidence by outcome

Each outcome is graded on its own evidence — a compound can be strong for one use and unproven for another. See how we grade.

Tendon and ligament healing
DPreclinical

Promising in rats; not demonstrated in humans. — Multiple rodent studies report accelerated tendon-to-bone healing and fibroblast activity, but no controlled human trials confirm this.

Gut / GI protection
DPreclinical

Animal data only. — Rodent models show protection against NSAID- and stress-induced gastrointestinal injury; human evidence is anecdotal.

Muscle and soft-tissue recovery
DPreclinical

Preclinical signal, no human confirmation.

Any long-term safety outcome
UUnknown

Unknown — no controlled human safety data exist.

Safety

Common adverse effects

  • Not established in humans; injection-site reactions reported anecdotally

Serious risks

  • Unknown — no controlled human safety data; unregulated product quality and contamination risk

Contraindications

  • No human contraindication data; not approved for human use

References

  1. Sikiric P et al. Stable Gastric Pentadecapeptide BPC 157 — review of tissue-healing research. Current Pharmaceutical Design (2018)
  2. FDA. 503A Bulk Drug Substances Nominated for Use in Compounding (BPC-157 evaluation)